Background. In the last 20 years, pharmaceutical care has evolved as a modus operandi for community pharmacy. This article tracks the development of pharmaceutical care for drug misusers since 1995 and considers the implications for pharmacy engagement with the wider care team. Objective. To survey current community pharmacy service provision for drug misusers, past training and future training needs and compare with data from previous years (1995, 2000 and 2006). Method. A cross-sectional postal questionnaire of pharmacy managers in Scotland (n = 1246), and telephone interviews with non-respondents. Results were compared with previous surveys. Results. The response rate was 70% (873) including 13.2% (164) by telephone. More pharmacies dispensed methadone in 2014 (88.5%) than previously, a significant increase across all time points (1995, 2000 and 2006) (P < 0.001). Most pharmacies (88.1%) had some drug misusers registered for the minor ailment scheme. In 2014, 43.4% of pharmacists always reported a drug misuser's non-attendance for opiate replacement treatment (ORT) to the prescriber (36.6% in 2006). If patient intoxication was suspected, medication was always withheld by 47.9% (27.5% in 2006). Pharmacists undertaking training in drug misuse and blood-borne diseases increased significantly since 1995, to 78.6% and 48.7%, respectively, in 2014 (P < 0.001). The preferred topic for future training was communication/engagement with other services. Conclusion. Pharmaceutical care for drug misusers has evolved from ORT supply to a more clinical approach. Pharmacists actively monitored ORT patients, managed their minor ailments and increasingly engaged with the wider care team.
Introduction
Pharmacists are increasingly involved in providing treatment for drug misusers as part of the primary care team, and dispensing opiate replacement treatment (ORT) in the form of methadone and buprenorphine is now a core function for community pharmacies in Scotland (1) . In this article, we consider how services have evolved, fit within the overarching concept of pharmaceutical care and reflect on the implication of these changes for integration into the wider care team for drug misusers.
A goal of pharmaceutical care is to improve the quality of life of patients through medication-related activities. Hepler and Strand (2) defined this as 'the direct or indirect responsible provision of drug therapy for the purpose of achieving the elimination or reduction of a patient's symptomatology; arresting or slowing of a disease process; or preventing a disease or symptomatology'. Pharmaceutical care of drug misusers therefore goes beyond supply of medicines such as ORT and encompasses notions of prevention of harm and facilitation of treatment adherence. There is evidence from previous research that some pharmacists do provide extra care in the form of advice and information (3) and community pharmacy generally is moving from a supply function to a more holistic role.
The change from supply to clinically orientated pharmacy practice is reflected in the knowledge and skills pharmacists acquire during formal training and alterations to their premises such as the inclusion of consulting rooms or private areas for confidential discussions. In England, the Now or Never report (2013) on pharmacy emphasized the need to improve collaborative working across community, primary and social care. The report also recognized the role of pharmacists in providing pharmaceutical care, improving the quality of care for people with long-term conditions and early detection of problems or deterioration, through routine monitoring (4) . An Audit Scotland report on health inequalities (2012) highlighted the importance of using the pharmacy network to further develop accessible services for substance misuse (5) . A recent Scottish pharmacy strategy document, Prescription for Excellence (2013) placed increased focus on anticipatory care, early intervention and developing pharmaceutical care for specific groups such as substance misusers (6) . All of these strategic plans indicated a more involved role for pharmacists in the treatment of drug misusers.
One area of pharmaceutical care for drug misusers that can be developed is applying the minor ailment scheme (MAS) as part of their overall care. The MAS emerged from the broader role for community pharmacies. Patients who have proof of exemption from NHS prescription charges, such as most drug misusers, can register on the MAS with a community pharmacy of their choosing. This allows patients' details to be checked at each presentation with common illness symptoms for pharmacy treatment, advice or referral as appropriate (7) .
A particular challenge of pharmaceutical care for drug misusers is to overcome potential stigmatization to ensure this patient group has equality with other patients (8) . Negative attitudes can sometimes affect interactions leading to a lack of mutual co-operation between patients and health professionals (9) . In the past, some drug misusers using pharmacy services have been met with stigmatized attitudes (10) . Drug misusers may feel embarrassed or ashamed when approaching pharmacy staff or they may perceive that stigma exists in the way they are treated (11) . Key factors to consider are that negative attitudes of staff, if perceived by the misuser, could lead to disruptive behaviour but if drug misusers recognize that negative behaviour will not be tolerated they will endeavour to behave appropriately so that their needs are met (9) . However, since Matheson's original work on stigma in the pharmacy in 1998 (10), there has been considerable expansion of pharmacy services and pharmacists' attitudes to drug misusers have improved significantly (3); therefore, stigmatization may have decreased although this has not been explored.
Four national surveys have been conducted in Scotland of the whole population of community pharmacies in 1995 (12), 2000 (13) , 2006 (3) and 2014 (1), to map service provision and pharmaceutical care for drug misusers. Survey topics included dispensing and supervision of replacement methadone and buprenorphine (buprenorphine was licensed for ORT in 1999 and slowly introduced in Scotland thereafter) and aspects of pharmacy practice around services for drug misusers such as health promotion activities in the form of supplying information and face-to-face advice on drug misuse and blood-borne diseases (1) .
Objective of the study
The aims of this study were to explore changes in pharmaceutical care provision for drug misusers in Scottish community pharmacies. These changes were linked to dispensing practices, provision of advice and information, liaison with prescribers and pharmacist training levels across four time points between 1995 and 2014.
Method
A cross-sectional postal survey was undertaken in 2014 using the data collection tool used previously (in 1995, 2000 and 2006) . Minimal amendments were made to capture new developments in practice while allowing for comparison with previous surveys. The postal questionnaire contained 65 questions and covered attitudes to drug misusers and the community pharmacist's role in managing drug misuse, levels of service provision (dispensing and prescribing ORT and naloxone, provision of injecting equipment, advice and information, dispensing practice and management of drug misusers in the pharmacy), training levels and needs, and demographics. Results from the questions on levels of service provision and attitudes towards service provision are presented elsewhere (1) .
As in 1995, 2000 and 2006, questionnaire packs were sent to all community pharmacies in Scotland (n = 1246) for the attention of the 'Pharmacist in Charge' containing an information sheet, letter of introduction, questionnaire, reply-paid envelope and identifiable postcard. Responding pharmacists were invited to return the postcard separately but concurrently with the returned questionnaire ensuring anonymity for respondents, while allowing followup of non-respondents. Against a backdrop of falling responses to questionnaires by health professionals (14) , additions were made to the 2014 survey methods to boost the response rate. These were the offer to enter respondents into a prize draw (if the pharmacist was willing to provide their name on the postcard to enable this), an endorsement letter from the Royal Pharmaceutical Society and an email from Area Specialist Pharmacists in Substance Misuse to encourage participation.
Questionnaires were posted in April 2014 and a reminder was sent after 3 weeks. After a further 2 weeks, telephone calls were made to non-respondents as a further reminder and to offer the opportunity of completing a shortened questionnaire by telephone interview if preferred. This shortened questionnaire contained 12 core questions on service provision, which were considered essential.
All data were entered, stored and managed following university guidelines to protect anonymity and confidentiality. Data were entered into an SPSS database by an administrator and the research assistant. A random 10% was checked for accuracy by another research assistant. An additional combined data set was created using core data common to the 2014 survey and the previous three surveys (1995, 2000 and 2006) . Comparisons were performed based on four independent cohorts as it was not possible to link pharmacies over time. One-way analysis of variance and chi-square test for trend were used for comparison of categorical variables. Demographics for 2014 only are presented here while previous survey demographics are published elsewhere (1).
Results

Response and demographics (2014)
In 2014, there were 709 (57%) respondents to the postal questionnaire and a further 164 (13%) to the reduced telephone questionnaire totalling 873 (70%) responses to core variables. A 10% data check for accuracy found an error rate of 0.01%. The median age of respondents was 40 years (range 22-68 years, standard deviation 11.4), and 444 respondents (62.6%) were female. Pharmacies were located in rural (175, 24.7%), urban (335, 47.2%) and city centre/ suburban locations (185, 26.1%). Types of business were reported as follows: single outlets (105, 14.8%), small multiples (164, 23.1%), large multiples (342, 48.2%), health centres (12, 1.7%) and large multiples within health centres (5, 0.7%).
ORT dispensing over time (1995, 2000, 2006 and 2014) In 2014, 773 (88.5%) respondents dispensed methadone to drug misusers, compared to 79.1% in 2006, 68.9% in 2000 and 54.6% in 1995. There was a significant increase across all time points in mean numbers of methadone clients per pharmacy (P < 0.001). A significant increase across time was also found in the mean numbers of patients per pharmacy receiving a supervised methadone consumption service (P < 0.001). While this figure doubled overall between 1995 and 2014, the largest increase was between 2000 and 2006 (see Table 1 ). There were also significant increases across all time points in the numbers of pharmacies who always checked whether a dose had been swallowed; this increase was largely in the 1995-2000 period (see Table 2 ).
A small number of pharmacists did not supervise methadone consumption in 2014 (n = 32/762, 4.2%); the majority of these (n = 28/30, 93.3%) said they would be prepared to supervise consumption in the future. In 1995, higher numbers reported they did not supervise consumption but fewer of those were prepared to do so in the future (n = 129, 49.4%). Across all time points between 1995 and 2014, there were smaller numbers not supervising but significantly higher percentages of those were prepared to do so in the future (P < 0.001) (see Table 2 ).
In 2006, 190 patients were dispensed buprenorphine by 161 (21.4%) pharmacies with supervised consumption on the pharmacy premises by 55 (28.6) pharmacies. The number of patients receiving buprenorphine increased to 1777 in 2014, provided by 462 (52.9%) pharmacies. Supervised consumption of buprenorphine was provided by 339 (73.4%) pharmacies, and a large majority of those checked that the tablet was fully dissolved (96.2% in 2014 compared to 91.1% in 2006).
A total of 455 (76.5%) respondents reported they had withdrawn methadone dispensing from a particular drug-misusing patient. The most frequently noted reasons for this were as follows: violence, threatening or abusive behaviour (209, 45.9%), shoplifting/theft/ stealing (200, 43.9%), being intoxicated or high (146, 32.1%), nonattendance at appointments (33, 7.2%) and altering or falsifying prescriptions (25, 5.5%); six (1.3%) methadone-dispensing withdrawals were due to the patient breaking agreed contract rules and five (1.1%) due to not swallowing. There were two episodes of misusers sharing methadone with others, one other misuser was imprisoned, one prescriber stopped the service and there were eight (1.8%) other instances of service withdrawal for unspecified reasons (respondents were allowed more than one answer, therefore proportions total >100).
Training
In 2014, three-quarters of pharmacists reported that they had undergone training in drug misuse. Across the four time points the numbers who had received training increased significantly (P < 0.001) but there was no linear trend (P = 0.262). Just under 50% of pharmacists reported in 2014 they had undergone training in the prevention of blood-borne diseases, which was a significant increase compared to previous years (P < 0.001). With respect to future training requirements, proportions remained relatively constant at ~75% for both drug misuse and prevention of blood-borne diseases, although the small differences observed were statistically significant (P < 0.001) (see Table 2 ). A range of past training types had been used, and formats for future training were offered; Table 3 presents preferences for future training. Free-text responses on preferred topics for future training for the 2014 respondents included engagement with prescribers, local addiction teams and experts and other stakeholders (n = 13); blood-borne and other diseases and prevention (n = 10), methadone interactions, revision, withholding long-term maintenance and coming off ORT (n = 9); and psychology and counselling for drug misusers (n = 6); other topics are detailed in Table 3 .
Dispensing practice and pharmaceutical care
New questions for 2014 found pump-dispensing systems were used by 255 (39.5%) pharmacists and 94 (14.6%) pharmacists used a photo ID system. Furthermore, the majority of pharmacies in 2014 (621, 88.1%) had some drug misusers registered with the electronic MAS (eMAS).
There was a slight increase in the percentage of pharmacists who always laid down ground rules for new clients in 2014 (90.4%) compared to 2006 (84.5%) but during this period there was a substantial increase in pharmacists always asking drug misusers for A larger increase was found in proportions of pharmacists providing information leaflets on drug misuse across the years compared to giving information leaflets on HIV prevention (see Table 4 ). As in previous years, along with increases in positive attitudes towards drug misusers, high percentages of pharmacists responded that they 'treated drug misusers the same as other customers'. This figure has increased across all four time points from 75.2% in 1995 to 93% in 2014 (see Table 4 ). If a drug misuser did not attend the pharmacy when expected, the incident was always reported to the prescribing doctor by 43.4% of pharmacists in 2014 (compared to 36.6% in 2006, P < 0.001). If a pharmacist suspected the patient was intoxicated, medication was always withheld by 47.9% of pharmacists in 2014 (compared to 27.5% in 2006, P < 0.001). However, there was a significant decrease in instances in which requests for needles and syringes from patients on ORT were always reported to the prescribing doctor (10.1% in 2014 compared to 15.6% in 2006, P < 0.001) (see Table 5 ).
Discussion
This survey, the fourth of a series of studies carried out over a period of 20 years, has enabled analysis and reflection on how pharmaceutical care of drug misusers has evolved at a national level. Questionnaire responses were necessarily anonymous and data collection therefore was based on four separate pharmacy populations. As expected, response rates were slightly lower than in previous years despite the extra measures taken to boost response. Telephone call reminders and offering shortened telephone questionnaires proved time-consuming for the researchers but boosted response.
There was an expansion of ORT services and more drug misusers were encouraged to take up treatment between 1995 and 2000. Alongside this was considerable investment in pharmacy services for drug misusers, with appointments of specialist pharmacists, contracts with specialist services, remuneration, shared-care schemes, the development of guidelines, a distance learning package and a variety of local and national training events. These data reflect those changes particularly in the change of training levels, checking doses are swallowed in the pharmacy and in 'treating drug misusers the same as other customers'. After these initial rises, these aspects of practice became 'normal', so no further rises were particularly evident.
Pharmaceutical care has evolved in several ways. There was a move to automated dispensing using pump-dispensing systems and photo identification systems. While in the past making up prescriptions in advance reduced the waiting time for patients, if a pumpdispensing system was used, this was not required as the dispensed dose was measured directly. Such systems made the dispensing process more efficient for the benefit of patients and pharmacy staff.
This vulnerable patient group, who may often have other health problems associated with ORT, is sensitive to differences between how they are treated compared to other pharmacy customers and previous research highlighted the importance of treating drug misusers with sensitivity, and as individuals, which could build up trust and foster positive relationships (15) . It is encouraging that more pharmacists seemed willing to provide face-to-face advice, particularly on the management of drug misuse. Fewer pharmacists seemed willing to provide face-to-face advice on the prevention of bloodborne diseases but this service has increased over time. This was probably directly linked to training levels in these topics as there was higher training in management of drug misuse than for prevention of blood-borne diseases. However, fewer pharmacists have offered faceto-face advice on hepatitis C prevention, which is an opportunity for further training. Pharmacists were more likely to withhold doses if a patient was intoxicated, indicating increased pharmacists' awareness of the dangers of potential overdose in this situation. Pharmacists were also more likely in 2014 than 2006 to communicate to the prescriber if a patient did not collect their prescription, with almost half of pharmacists saying they would 'always' do this. This compares favourably to 20% of English pharmacists (16) Although there were still reported incidences of negative behaviours of some drug misusers resulting in withdrawal of dispensing services from some individuals, this did not appear to have affected willingness to provide this service for others. Indeed attitudes have become significantly more positive over time (1) and respondents increasingly reported they treated misusers the same as other customers. There may be some social desirability bias in answering this question about treating drug misusers the same as other customers (pharmacists may want to believe they treat drug misusers the same as other customers). However, an overall trend to more equitable treatment of this patient group with time suggests that respondents are answering truthfully. The number of respondents who reported they have, in the past, withdrawn dispensing methadone to a particular drug misuser was similar to Winstock's 2008 study, which reported that 80% of pharmacists had refused to provide a dose in the previous year for any reason (15) .
A high proportion of pharmacies have drug misusers registered for the eMAS in the pharmacy. This service was introduced into the community pharmacy contract in 2006, and this is therefore the first time this data could be collected; future research will determine any changes in levels of provision of this service for drug misusers. By having their drug-misusing patients on the eMAS, pharmacists can provide more holistic care, including managing the side effects of opiate treatment and identifying other health problems earlier.
Since 2000, there have been comparable levels of respondents who have had professional training on drug misuse, and across all four survey points pharmacists were willing to undertake further drug misuse training. Past training on the prevention of blood-borne diseases was less than for drug misuse, but many pharmacists would like further training for this, suggesting a training gap (see Table 2 ). This is particularly relevant given the ongoing problematic outbreaks of bacterial infections in injecting drug users across the UK as well as the high levels of hepatitis C virus (17) . The preferred format of future learning indicated the increased use of online methods such as webinars.
Further research could explore how recent initiatives and changes in service provision in pharmacies, for example use of automated dispensing systems have affected users' perceptions and behaviour. There is a need to further develop the pharmaceutical care role into a preventative one in which problems such as potential relapse, identified through missed doses or intoxication, are identified earlier and communicated to the clinical team. There was clearly increased willingness to communicate more with the clinical team as demonstrated through both increased communication and expressed preferences for future training. This could be capitalized upon to improve patient care. 
Conclusion
There is evidence that pharmaceutical care for drug misusers has evolved from a supply of ORT to a broader, more clinical approach. Pharmacists appear more active in their monitoring of patients on ORT; they provide advice and information on drug misuse and the prevention of blood-borne diseases as well as managing minor ailments. They have increasingly invested in this patient group through specialist-dispensing systems and are willing to advance their professional knowledge and skills through training. Pharmacists were keen to engage with the wider care team managing drug misusers. 
